Insulin-Resistant Cardiomyopathy
Why the study?
Insulin resistance is increasingly recognized as a primary etiologic factor in nonischemic heart failure, but its role and therapeutic implications require comprehensive review.
Does the combination of green tea and green coffee extract improve cardiac insulin resistance in a rat model of metabolic syndrome?
Key Points
- To review basic science, animal experimental data, and human clinical evidence examining insulin resistance as a primary cause of nonischemic heart failure and evaluate potential targeted therapies.
- Reviewed cellular pathways, animal models of metabolic heart disease, and human clinical trial data assessing the link between insulin resistance and nonischemic heart failure.
- Evaluated the impact of impaired myocardial substrate metabolism on cardiac injury, prognosis, and response to antiadrenergic therapy.
- Assessed potential treatment strategies including metabolic-modulating agents and antidiabetic drugs.
- Insulin resistance disrupts normal adaptive substrate metabolism in the injured myocardium, promoting lipotoxicity, inflammation, oxidative stress, sympathetic up-regulation, and fibrosis.
- Animal models demonstrate an insulin-resistant cardiomyopathy with inefficient myocardial energy use that is reversible upon improving energy utilization.
- In human clinical data, insulin resistance is highly prevalent in nonischemic heart failure, precedes disease onset, independently predicts worse prognosis, and determines responsiveness to antiadrenergic therapy.
Structured PICO
Does the combination of green tea and green coffee extract improve cardiac insulin resistance in a rat model of metabolic syndrome?
P
Population
25 male Sprague-Dawley rats (aged 9 weeks) with diet- and streptozotocin-induced metabolic syndrome treated with extracts over 9 weeks.
I
Intervention
Combination of green tea extract (300 mg/kg/day) and decaffeinated light-roasted green coffee extract (200 mg/kg/day) administered orally for 9 weeks.
C
Comparator
Normal control group, untreated metabolic syndrome group, green tea extract alone (300 mg/kg/day), and decaffeinated light-roasted green coffee extract alone (200 mg/kg/day).
O
Outcome
Free fatty acid (NEFA) levels and insulin resistance (HOMA-IR) at 9 weeks.surrogate
Main Result
p-value: p=<0.001
Combining green tea and decaffeinated light-roasted green coffee extracts synergistically improves cardiac insulin resistance in a metabolic syndrome model by modulating adiponectin and fatty acid pathways.
Limitations
- Did not investigate the biomarker in adipose tissues
- Could not exhibit the molecular mechanisms for the effects of green tea and green coffee combination administration
- Did not investigate biomarkers in adipose tissues
- Could not exhibit the complete molecular mechanisms for the effects of the combined administration
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Almost certainly, insulin resistance itself is not enough to cause dilated cardiomyopathy; the very fact that the vast majority of patients with insulin resistance do not develop dilated cardiomyopathies highlights this point.”
Implication
May support metabolic interventions for insulin-resistant cardiomyopathy in metabolic syndrome models; extends reversibility findings but leaves open human translation.
Abstract
Increasing evidence points to insulin resistance as a primary etiologic factor in the development of nonischemic heart failure (HF). The myocardium normally responds to injury by altering substrate metabolism to increase energy efficiency. Insulin resistance prevents this adaptive response and can lead to further injury by contributing to lipotoxicity, sympathetic up-regulation, inflammation, oxidative stress, and fibrosis. Animal models have repeatedly demonstrated the existence of an insulin-resistant cardiomyopathy, one that is characterized by inefficient energy metabolism and is reversible by improving energy use. Clinical studies in humans strongly support the link between insulin resistance and nonischemic HF. Insulin resistance is highly prevalent in the nonischemic HF population, predates the development of HF, independently defines a worse prognosis, and predicts response to antiadrenergic therapy. Potential options for treatment include metabolic-modulating agents and antidiabetic drugs. This article reviews the basic science evidence, animal experiments, and human clinical data supporting the existence of an "insulin-resistant cardiomyopathy" and proposes specific potential therapeutic approaches.
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Witteles et al. (2008) studied Metabolic syndrome (n=25). Combination of green tea and decaffeinated light-roasted green coffee extract vs. Untreated metabolic syndrome, green tea alone, green coffee alone, or normal control was evaluated on Homeostatic model assessment for insulin resistance (HOMA-IR) index and free fatty acid (NEFA) levels (p=<0.001).